Benjamin L. Palleiko
2020
In 2020, Benjamin L. Palleiko earned a total compensation of $1M as Chief Business Officer and Chief Financial Officer at Carbylan Therapeutics, a 51% decrease compared to previous year.
Compensation breakdown
| Option Awards | $581,580 |
|---|---|
| Salary | $435,000 |
| Other | $11,900 |
| Total | $1,028,480 |
Palleiko received $581.6K in option awards, accounting for 57% of the total pay in 2020.
Palleiko also received $435K in salary and $11.9K in other compensation.
Rankings
In 2020, Benjamin L. Palleiko's compensation ranked 8,517th out of 13,090 executives tracked by ExecPay. In other words, Palleiko earned more than 34.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,517 out of 13,090 | 35th |
Division Manufacturing | 3,620 out of 5,621 | 36th |
Major group Chemicals And Allied Products | 1,463 out of 2,254 | 35th |
Industry group Drugs | 1,274 out of 1,954 | 35th |
Industry Pharmaceutical Preparations | 940 out of 1,459 | 36th |
Source: SEC filing on August 25, 2020.
Palleiko's colleagues
We found two more compensation records of executives who worked with Benjamin L. Palleiko at Carbylan Therapeutics in 2020.